Elevated ROCK1 and/or ROCK2 expression was associated with shorter survival in human pancreatic cancer patients, while conditional ROCK activation in KrasG12D‐driven PDAC mice was sufficient to accelerate mortality. Here, ROCK2 is linked to familial pancreatic carcinoma.